These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2188845)

  • 1. A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers.
    McVeigh GE; McMaster M; Linton T; Whitehead E; Johnston GD
    Eur J Clin Pharmacol; 1990; 38(4):351-7. PubMed ID: 2188845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
    McVeigh G; Galloway D; Johnston D
    BMJ; 1988 Jul; 297(6641):95-8. PubMed ID: 3044503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertension.
    Passmore AP; Whitehead EM; Crawford V; McVeigh GE; Johnston GD
    Q J Med; 1991 Nov; 81(295):919-28. PubMed ID: 1808632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low versus conventional dose cyclopenthiazide on platelet intracellular calcium in mild essential hypertension.
    McVeigh GE; Copeland S; McKellar J; Johnston D
    J Hypertens; 1988 Apr; 6(4):337-41. PubMed ID: 3288695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J; Wuerzner G; Jensen C; Brunner HR
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
    Wray R; Benton KG; Whitehill D; Wright B; Weener W; Whittington JR
    Curr Med Res Opin; 1983; 8(9):665-74. PubMed ID: 6365467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.
    MacGregor GA; Banks RA; Markandu ND; Roulston J
    Br J Clin Pharmacol; 1982 Jun; 13(6):859-63. PubMed ID: 7046777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
    Goldberg MR; Tanaka W; Barchowsky A; Bradstreet TE; McCrea J; Lo MW; McWilliams EJ; Bjornsson TD
    Hypertension; 1993 May; 21(5):704-13. PubMed ID: 8491505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension.
    McVeigh GE; Dulie EB; Ravenscroft A; Galloway DB; Johnston GD
    Br J Clin Pharmacol; 1989 Apr; 27(4):523-6. PubMed ID: 2655692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH
    S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure.
    Hoffman DM; Crampton L; Sernia C; Nguyen TV; Ho KK
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1123-8. PubMed ID: 8772586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-ranging study of the angiotensin II receptor antagonist irbesartan (SR 47436/BMS-186295) on blood pressure and neurohormonal effects in salt-deplete men.
    McIntyre M; MacFadyen RJ; Meredith PA; Brouard R; Reid JL
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):101-6. PubMed ID: 8797143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients.
    Bolli P; Simpson FO; Waal-Manning HJ
    Lancet; 1978 Sep; 2(8090):595-8. PubMed ID: 80525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the mechanism of beta 2-agonist-induced activation of the renin-angiotensin system.
    Millar EA; McInnes GT; Thomson NC
    Clin Sci (Lond); 1995 Apr; 88(4):433-7. PubMed ID: 7789045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
    Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
    J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral diuretics and hypertension.
    Waal-Manning HJ
    N Z Med J; 1982 Apr; 95(706):287-8. PubMed ID: 6953383
    [No Abstract]   [Full Text] [Related]  

  • 17. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrarenal contributions to indapamide's antihypertensive mechanism of action.
    Noveck RJ; McMahon FG; Quiros A; Giles T
    Am Heart J; 1983 Jul; 106(1 Pt 2):221-9. PubMed ID: 6869204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the acute effects of angiotensin II by the receptor antagonist irbesartan in normotensive men.
    Ribstein J; Picard A; Armagnac C; Sissmann J; Mimran A
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):449-60. PubMed ID: 11300658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.